PTPRC and neoplasm: These results showed that immune factors such as CD8+ TILs, CD45+ TILs, CD45RO+ TILs, PD1+ TILs and tumor PD-L2 expression have clinical prognostic relevance for advanced stage colon carcinoma patients.